Oral-lyn Results for Type 1s

Results Demonstrate Metabolic Control in Diabetes Showed a Significant Improvement When Compared to Standard Therapy. Three-month results of a long-term six-month clinical trial performed in 24 adolescents and 5 young adult patients with Type-1 diabetes mellitus (DM) using Oral-lyn, the buccal insulin. This data continuously showed that replacing just 1 one daily subcutaneous injection (s.c.) of regular insulin with Generex Oral-lyn™ during the day, improves parameters of metabolic control in the same manner observed with intensively monitored standard therapy.

At the 3rd month evaluation of this six-month trial, it was demonstrated that a trend similar towards normalization exists when replacing the lunch-time dose of regular insulin with the Generex Oral-lyn™ spray. In fact, not only Daily Glucose Profiles and Fructosamine demonstrated improved values but, of special importance, Glycosylated Hemoglobin (HbA1c), the criterion standard to evaluate metabolic control in Diabetes, showed a significant improvement when compared to standard therapy. The investigators concluded, in their three-month interim analysis, that successful and efficient replacement of injected regular insulin at lunchtime was achieved with Generex Oral-lyn™ altogether with 100% compliance.

These encouraging results prompted the investigators and the partners Generex-Pharmabrand to design studies using larger number of Type-1 DM subjects and replacing the three mealtime doses of regular insulin with the Generex-Oral-lyn™ spray on subjects maintained in once daily glargine insulin therapy.
Results Presented at a Marketing Program Sponsored by Company’s Joint Venture Partner, PharmaBrand SA
Learn about the Steps To Health, a program to increase physical activity that has gone through 8 years of clinical studies to show its effectiveness.
https://www.steps-to-health.org

===========================
Advertisement
Come Experience Pri-Med – The leading Conference in the US for primary care clinicians
providing world-class, current and clinically-relevant continuing medical education. Pri-Med presents clinicians in various specialties with education and information about the very latest advances in research, treatment protocols and technology that directly improve the quality of care. Expert speakers from nationally recognized institutions present sessions on clinical challenges you regularly encounter in your practice. Visit pri-med.com for complete conference details.
https://www.pri-med.com/pmo/LiveProgramDetail.aspx?Brand=10